2018-07-30T15:04:17-05:00 2017-09-29 910189318 Moss Adams LLP 6565 Americas Parkway NE Ste 600 Albuquerque NM 87110 990 2016-10-01 850110669 Lovelace Respiratory Research Institute LOVE 5053489389 2425 Ridgecrest Drive SE Albuquerque NM 87108 Shannon Toma Chief Operating Officer 5053489389 2018-07-30 1 Pamela Alexanderson P01218925 5058787200 2018-07-30 2016 2022-09-23 18:48:47Z Robert W Rubin 2425 Ridgecrest Drive SE Albuquerque NM 87108 10561162 0 X WWW.LRRI.ORG X 1965 NM THE LOVELACE RESPIRATORY RESEARCH INSTITUTE (LRRI) IS A PRIVATE, BIOMEDICAL RESEARCH ORGANIZATION DEDICATED TO IMPROVING PUBLIC HEALTH THROUGH RESEARCH ON THE PREVENTION, TREATMENT AND CURE OF RESPIRATORY DISEASE. LRRI IS COMMITTED TO CURING RESPIRATORY DISEASES THROUGH RESEARCH AIMED AT UNDERSTANDING THEIR CAUSES AND BIOLOGICAL MECHANISMS; ASSESSING AND ELIMINATING EXPOSURES TO RESPIRATORY HEALTH HAZARDS; AND DEVELOPING IMPROVED THERAPEUTICS, VACCINES, AND DIAGNOSTICS. LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE (LBERI) IS A WHOLLY OWNED SUBSIDIARY OF LOVELACE RESPIRATORY RESEARCH INSTITUTE (LRRI). LRRI MANAGES ALL GOVERNMENT CONTRACTS FOR LBERI. LBERI OFFERS CAPABILITIES FOR RESEARCH, DEVELOPMENT, TESTING, AND EVALUATION (RDT&E) TO PROVIDE IMPROVED MEDICAL COUNTERMEASURES AGAINST CHEMICAL, BIOLOGICAL, RADIOLOGICAL, NUCLEAR (CBRN), EMERGING, AND ENVIRONMENTAL THREATS. LRRI IS BASED IN ALBUQUERQUE, NEW MEXICO. 19 18 62 18 0 0 52 65 16751716 9493238 4803765 1211528 -316658 -164787 21238875 10540044 0 0 0 0 8894499 7521547 0 0 0 9901939 13038349 18796438 20559896 2442437 -10019852 66527886 61729283 28524158 32677278 38003728 29052005 X THE LOVELACE RESPIRATORY RESEARCH INSTITUTE (LRRI) IS A PRIVATE, BIOMEDICAL RESEARCH ORGANIZATION DEDICATED TO IMPROVING PUBLIC HEALTH THROUGH RESEARCH ON THE PREVENTION, TREATMENT AND CURE OF RESPIRATORY DISEASE. LRRI IS COMMITTED TO CURING RESPIRATORY DISEASES THROUGH RESEARCH AIMED AT UNDERSTANDING THEIR CAUSES AND BIOLOGICAL MECHANISMS; ASSESSING AND ELIMINATING EXPOSURES TO RESPIRATORY HEALTH HAZARDS; AND DEVELOPING IMPROVED THERAPEUTICS, VACCINES, AND DIAGNOSTICS. LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE (LBERI) IS A WHOLLY OWNED SUBSIDIARY OF LOVELACE RESPIRATORY RESEARCH INSTITUTE (LRRI). LRRI MANAGES ALL GOVERNMENT CONTRACTS FOR LBERI. LBERI OFFERS CAPABILITIES FOR RESEARCH, DEVELOPMENT, TESTING, AND EVALUATION (RDT&E) TO PROVIDE IMPROVED MEDICAL COUNTERMEASURES AGAINST CHEMICAL, BIOLOGICAL, RADIOLOGICAL, NUCLEAR (CBRN), EMERGING, AND ENVIRONMENTAL THREATS. LRRI IS BASED IN ALBUQUERQUE, NEW MEXICO. 0 0 16223097 9304942 Medical research and educational activity in the areas of basic biomedical research, health and population studies, primarily in respiratory diseases such as asthma, copd, allergy and toxic effects of environmental factors. 16223097 1 0 0 1 0 0 0 0 0 0 1 0 1 0 1 1 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 1 1 1 0 0 0 1 54 0 1 62 1 0 0 0 0 0 0 0 0 0 0 X 19 18 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 NM X X Shannon Toma 5053489389 2425 RIDGECREST DRIVE SE ALBUQUERQUE NM 87108 Jackie Lovelace Johnson Chairman of the Board 2.00 4.00 X X 0 0 0 Robert Rubin PHD CEO, President, Director 2.00 48.00 X X 0 1213540 41105 James Swenberg DVM PHD Dir, Chair - Research Program Oversight 2.00 0.00 X X 0 0 0 Jane Delgado Dir, Chair - Nominating Committee 2.00 0.00 X X 0 0 0 Chris Spencer CPA Dir, Chair - Budget & Finance 2.00 2.00 X X 0 0 0 Pamela Sullivan Dir, Chair - Audit & Compensation Committee 2.00 0.00 X X 0 0 0 David Durgin Dir, Chair - Alternative Investment Committee 2.00 0.00 X X 0 0 0 Gregory Downey MD Director 2.00 0.00 X 0 0 0 J Grant Burcham Director 2.00 0.00 X 0 0 0 Jack McCarthy MD Director 2.00 0.00 X 0 0 0 Joe Fulcher Director 2.00 0.00 X 0 0 0 Major General John Doesburg Director 2.00 0.00 X 0 0 0 Melvin Twiest MD Director 2.00 0.00 X 0 0 0 Augustine Choi MD Director 2.00 0.00 X 0 0 0 Sara Easterson-Bond Director 2.00 2.00 X 0 0 0 Tess Burleson Director 2.00 2.00 X 0 0 0 Richard Gill PHD Director 2.00 0.00 X 0 0 0 Sandra Chavez Director 2.00 0.00 X 0 0 0 Terry Dunlay Director 2.00 0.00 X 0 0 0 Shannon Toma Treasurer, COO, CFO 42.00 6.00 X 299446 0 37767 David Byrd through- 041917 CFO 2.00 44.00 X 157834 0 17813 Margaret Dunbar Throug - 08252017 Gnrl Cnsl & SR Dir of Bus Affa- Former 40.00 0.00 X 180467 0 26170 Matthew Reed Dir PreClin Drug Dev/Scientist 40.00 0.00 X 193938 0 31392 Chester Leach Scientist Emeritus 16.00 0.00 X 219166 0 10089 David Flanders Human Resources Vice President 40.00 0.00 X 173462 0 22730 Lucille Maestas Former - 012717 Assoc Director of ORC and PMO - Former 40.00 0.00 X 142683 0 15208 Julie Nickerson Former - 121916 Controller - Former 40.00 0.00 X 138779 0 18322 1505775 1213540 220596 10 0 1 0 Moss Adams LLP 6565 Americas Parkway NE Suite 500 Albuquerque NM 87110 Audit, Tax Return Preparation 283031 CMGRP Inc DBA Cassidy & Associates 700 13th Street NW Suite 400 Washington DC 20005 Lobbying 207643 Sabio Systems 4520 Montgomery NE Suite 2 Albuquerque NM 87109 Staffing Company 178491 Robert Half Technology PO Box 60000 File 73484 San Francisco CA 94160 Staffing Company 118217 Kinetek Consulting LLC 318 Indian Trace 700 Weston FL 33326 Consulting 100085 6 65 65 BIOMEDICAL RESEARCH 541700 9475803 9475803 Revenue from SSA 900099 17435 17435 9493238 1232646 1232646 15834 15834 21118 -21118 -21118 -21118 Loss on Joint Venture 900000 -188296 -188296 7675 7675 -180621 10540044 9304942 0 1235037 1236911 1236911 5890317 3087702 2802615 124022 124022 270297 115321 154976 67085 67085 546076 546076 35580 35580 -225077 4005399 -4230476 56969 37164 19805 272646 53649 218997 686752 7224 679528 355464 63726 291738 235478 147546 87932 81452 33730 47722 894284 894284 579647 137438 442209 588621 588621 Intercompany Reimbursem 6084018 6084018 Research Supplies 2115333 2115333 SUPPLIES 280445 46927 233518 Bad Debt Expense 186920 186920 196656 101000 95656 20559896 16223097 4336799 0 3672377 0 270999 184000 2684445 1940940 625736 30152 28461 16778 620421 580485 798378 712344 17083067 12150483 5007729 4932584 45258026 48289718 6176652 3548815 1384662 1493467 66527886 61729283 1697474 1420948 1950880 394007 23491142 29368856 1384662 1493467 28524158 32677278 X 38003728 29052005 38003728 29052005 66527886 61729283 -10019852 4367053 -3298924 0 X 0 1 X 1 1 1 X 28445094 13513313 14045783 52 65 56004307 28445094 13513313 14045783 52 65 56004307 56004307 1299860 2187594 2873885 2099472 1248480 9709291 4064511 880 -339932 -188296 3537163 69250761 54779491 0.80870 0.86830 X Schedule A, Part II, Line 10, Explanation of Other Income: MISCELLANEOUS - 2012 Amount: $ 7,287. 2013 Amount: $ 880. 2015 Amount: $ 577. HIGH WAGE TAX CREDIT - other income rebates - 2012 Amount: $ 14,089. Technology Tax Credit - 2012 Amount: $ 721,424. Corporate Allocation - 2012 Amount: $ 3,321,711. Bad Debt Recovery - 2015 Amount: $ 33,646. Loss on Joint Ventures - 2015 Amount: $ -374,155. 2016 Amount: $ -188,296. X 0 191280 0 191280 10137079 54603552 10137079 54794832 656854 1000000 164214 250000 0 0 0 0 1000000 1000000 1000000 3000000 4500000 145058 168937 191280 505275 250000 250000 250000 750000 1125000 104544 106913 211457 13115736 9086568 4029168 3156431 2575171 581260 599443 488744 110699 4932584 Investment in LSR -911216 C Investment in MRN 4383772 C investment in joint venture 76259 C 3548815 DEFERRED COMP 457(B) and 457(f) 1493467 1493467 X Part X, Line 2: The Company is a nonprofit corporation and qualifies as a taxexempt organization under Section 501(c)(3) of the Internal Revenue Code and is classified as other than a private foundation. As such, its normal activities do not result in any income tax liabilities. However, income from certain activities not directly related to the Company's tax-exempt purpose is subject to taxation as unrelated business income. As of September 30, 2017, the Company continues to be qualified as a tax-exempt organization under Section 501(c)(3) of the IRC and had no unreported income derived from unrelated business activities and did not identify any entity level tax positions that would not meet the morelikelythannot threshold. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. There were no such interest or penalties recorded for the year ended September 30, 2017. The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal, state, local and foreign jurisdictions, where applicable. Middle East and North Africa 0 0 Program Services Research 236332 0 0 0 0 0 0 236332 0 236332 1 0 0 0 0 0 Part I, line 3: The organization uses the equity method of accounting to account for expenditures. X X 0 0 X X X 1 1 0 0 0 0 0 1 0 Robert Rubin PHD CEO, President, Director 0 609832 0 25000 0 578708 0 25881 0 15224 0 1254645 0 0 Shannon Toma Treasurer, COO, CFO 291446 0 8000 0 0 0 25881 0 11886 0 337213 0 0 0 David Byrd through- 041917 CFO 142834 0 15000 0 0 0 13612 0 4201 0 175647 0 0 0 Margaret Dunbar Throug - 08252017 Gnrl Cnsl & SR Dir of Bus Affa- Form 176467 0 4000 0 0 0 17631 0 8539 0 206637 0 0 0 Matthew Reed Dir PreClin Drug Dev/Scientist 190438 0 3500 0 0 0 19504 0 11888 0 225330 0 0 0 Chester Leach Scientist Emeritus 219166 0 0 0 0 0 0 0 10089 0 229255 0 0 0 David Flanders Human Resources Vice President 168362 0 5100 0 0 0 16892 0 5838 0 196192 0 0 0 Lucille Maestas Former - 012717 Assoc Director of ORC and PMO - Form 139183 0 3500 0 0 0 13385 0 1823 0 157891 0 0 0 Julie Nickerson Former - 121916 Controller - Former 138779 0 0 0 0 0 12682 0 5640 0 157101 0 0 0 Part I, Line 1a Tax indemnification and gross-up payments is checked for the SERP contribution for Robert W. Rubin. Part I, Lines 4a-b David Byrd - Severance - $15,500 Dr. Rubin 457(f) Plan - 2016 Contribution is $54,867. Dr Rubin also received a catch-up contribution in 2016 of $339,540. Since Dr. Rubin is vested in the 457(f) plan, the entire amount of his 2016 457(f) plan contribution is included in taxable income. Part I, Line 7 Bonuses are awarded annually. Management is provided an amount, approved by the board, to pay in annual bonus. Bonus payments are reviewed and approved by the employee's direct supervisor, human resources, CHRO and CEO. CEO bonus is established by the compensation committee of the Board of Directors. SHANNON TOMA EVP, COO IN CONNECTION WITH RELOCATION AGREEMENT X 50000 16778 0 1 1 16778 Form 990, Part VI, Section B, line 11b THE FORM 990 IS PRESENTED IN DRAFT FORM TO THE AUDIT AND COMPENSATION COMMITTEE AND TO THE FULL BOARD FOR REVIEW PRIOR TO SUBMISSION. Form 990, Part VI, Section B, line 12c THE ORGANIZATION HAS A CODE OF CONDUCT THAT ADDRESSES CONFLICTS OF INTEREST. IT IS PRESENTED TO THE BOARD ANNUALLY. ADDITIONALLY, ALL EMPLOYEES, INCLUDING OFFICERS, ARE REQUIRED TO READ AND ACKNOWLEDGE THE CODE ANNUALLY. IN ADDITION, IF A CONFLICT ARISES, THE CONFLICTED INDIVIDUAL RECUSES HIMSELF FROM VOTING ON THE ISSUE. Form 990, Part VI, Section B, line 15 THE ORGANIZATION'S AUDIT AND COMPENSATION COMMITTEES RECEIVE COMPENSATORY RECOMMENDATION FROM HUMAN RESOURCES AND FROM MANAGEMENT AS TO: 1. PERCENT BASE SALARY INCREASE FOR THE ORGANIZATION AS A WHOLE WITH TARGETS AND THE DOLLAR AMOUNT OF IMPACT ARE PRESENTED TO AND APPROVED BY THE AUDIT AND COMPENSATION COMMITTEE. 2. TARGET AMOUNT OF BONUS COMPENSATION FOR THE ENTIRE ORGANIZATION AND THE DOLLAR IMPACT ARE PRESENTED AND APPROVED BY THE AUDIT AND COMPENSATION COMMITTEE. 3. CEO COMPENSATION (BASE, BONUS AND DEFERRED COMPENSATION) IS REVIEWED TO MARKET VALUE FOR SIMILAR POSITIONS IN THE INDUCTRY AND APPROVED BY THE AUDIT AND COMPENSATION COMMITTEE. THIS PROCESS IS DOCUMENTED AND WAS LAST COMPLETED IN THE FALL OF 2016. Form 990, Part VI, Section C, line 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE PUBLIC DISCLOSURE COPY OF THE FORM 990 IS ALSO AVAILABLE VIA GUIDESTAR and at the new mexico Attorney General's Office's Charitable Organization Registration system (nm-coros). SANDIA STAFFING ALLIANCE LLC 6301 INDIAN SCHOOL RD NE SUITE 204 ALBUQUERQUE NM 87110 320210366 RESEARCH AUGMENTATION NM 0 0 Lovelace Respiratory Research Institute LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE 2425 RIDGECREST DRIVE SE ALBUQUERQUE NM 87108 510154068 BASIC AND APPLIED RESEARCH NM 501(c)(3) 7 LOVELACE RESPIRATORY RESEARCH INSTITUTE 1 THE MIND RESEARCH NETWORK 1101 YALE BLVD NE ALBUQUERQUE NM 87106 850457562 Medical research seeking the causes and cures for brain disorders NM 501(c)(3) 7 LOVELACE RESPIRATORY RESEARCH INSTITUTE 1 LOVELACE SCIENTIFIC RESOURCES 2441 RIDGECREST DR SE ALBUQUERQUE NM 87108 850357767 CLINICAL TRIALS AND OTHER MEDICAL SERVICES NM lovelace respiratory research institute C 3461809 1192039 1.00000 1 0 0 0 1 1 0 0 0 0 0 0 0 1 1 1 1 1 1 0 LOVELACE SCIENTIFIC RESOURCES Q 387471 Lovelace BIOMEDICAL AND ENVIRONMENTAL INSTITUTE Q 2158333 The Mind Research Network Q 1308433 Lovelace BIOMEDICAL AND ENVIRONMENTAL INST (not reportable less than 50K) N LOVELACE BIOMEDICAL AND ENVIRONMENTAL INSTITUTE P 1566640 The Mind Research Network P 152750 The Mind Research Network D 580485 Lovelace Biomedical and Environmental Institute 2425 Ridgecrest Dr SE Albuquerque NM 87108 540154068 X 0 191280 191280 0 191280 38256 9564 0 153024 0